Kippreport gets the scoop from Neelesh Bhatnagar, CEO of Emax, and Nadeem Khanzadah, head of omnichannel retail at Jumbo GroupSeptember 2, 2015 5:24
Around 35% of the medication sold in the Middle East is fake, compared to just 1% in the US. Kipp examines the threat posed by this $75 billion global trade, and what regional policymakers are doing about it.
March 15, 2010 7:50 by kippreport
A bitter pill
Figures from the World Health Organization suggest that up to 35 percent of all drugs in the Middle East may be fake, compared to less than 1 percent in the U.S. and Western Europe, according to a report in February’s Wall Street Journal.
The UAE faces a particular challenge, with smugglers abusing UAE ports and free zone areas to transit the contraband, ultimately bound for international destinations. In 2007, the World Health Organization estimated that counterfeit drugs may account for as much as 30 percent of all the goods seized in UAE ports.
According to the World Health Organization, “counterfeit medicines are deliber¬ately and fraudulently mislabeled with respect to identity or source: their quality is unpredictable as they may contain the wrong amount of active ingredients, wrong ingredients or no active ingredients”. In the most sinister cases, fake drugs can contain dangerous or even toxic chemicals that can harm or kill.
What are the hottest tech products in Dubai this year?
Infographic: 7 ways to stay happy at work
City Centre Me’aisem: The latest addition to Dubai’s retail family
Video profile: How Dubai’s fast-paced lifestyle affects what you eat
Is virtual reality the next ‘big thing’?